• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虚拟活检在肾肿物管理中的作用。

Role of Virtual Biopsy in the Management of Renal Masses.

作者信息

Diaz de Leon Alberto, Davenport Matthew S, Silverman Stuart G, Schieda Nicola, Cadeddu Jeffrey A, Pedrosa Ivan

机构信息

Department of Radiology, University of Texas Southwestern Medical Center, 2201 Inwood Rd, Ste 210, Dallas, TX 75225.

Departments of Radiology and Urology, Michigan Medicine, Ann Arbor, MI.

出版信息

AJR Am J Roentgenol. 2019 Jun;212(6):1234-1243. doi: 10.2214/AJR.19.21172. Epub 2019 Apr 17.

DOI:10.2214/AJR.19.21172
PMID:30995092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6800762/
Abstract

Renal masses comprise a heterogeneous group of pathologic conditions, including benign and indolent diseases and aggressive malignancies, complicating management. In this article, we explore the emerging role of imaging to provide a comprehensive noninvasive characterization of a renal mass-so-called "virtual biopsy"-and its potential use in the management of patients with renal tumors. Percutaneous renal mass biopsy (RMB) remains a valuable method to provide a presurgical histopathologic diagnosis of renal masses, but it is an invasive procedure and is not always feasible. Accumulating data support the use of imaging features to predict histopathology of renal masses. Imaging may help address some of the inherent limitations of RMB, and in certain settings, a multimodal clinical approach may allow decreasing the need for RMB.

摘要

肾肿物包括一组异质性的病理状况,涵盖良性和惰性疾病以及侵袭性恶性肿瘤,这使得管理变得复杂。在本文中,我们探讨了成像技术在对肾肿物进行全面无创特征描述(即所谓的“虚拟活检”)方面日益凸显的作用及其在肾肿瘤患者管理中的潜在应用。经皮肾肿物活检(RMB)仍然是为肾肿物提供术前组织病理学诊断的一种有价值的方法,但它是一种侵入性操作,并非总是可行。越来越多的数据支持利用成像特征来预测肾肿物的组织病理学。成像可能有助于解决RMB的一些固有局限性,并且在某些情况下,多模式临床方法可能会减少对RMB的需求。

相似文献

1
Role of Virtual Biopsy in the Management of Renal Masses.虚拟活检在肾肿物管理中的作用。
AJR Am J Roentgenol. 2019 Jun;212(6):1234-1243. doi: 10.2214/AJR.19.21172. Epub 2019 Apr 17.
2
Percutaneous biopsy for risk stratification of renal masses.经皮活检用于肾肿块的风险分层
Ther Adv Urol. 2015 Oct;7(5):265-74. doi: 10.1177/1756287215585273.
3
Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance.经皮影像引导下的肾脏实体肿块穿刺活检:安全性、有效性、病理解读和临床意义分析。
Abdom Radiol (NY). 2018 Jul;43(7):1813-1819. doi: 10.1007/s00261-017-1337-7.
4
Contemporary trends in percutaneous renal mass biopsy utilization in the United States.美国经皮肾肿瘤活检应用的当代趋势。
Urol Oncol. 2020 Nov;38(11):835-843. doi: 10.1016/j.urolonc.2020.07.022. Epub 2020 Sep 7.
5
Update on Indications for Percutaneous Renal Mass Biopsy in the Era of Advanced CT and MRI.先进CT和MRI时代经皮肾肿物活检指征的最新进展
AJR Am J Roentgenol. 2019 Jun;212(6):1187-1196. doi: 10.2214/AJR.19.21093. Epub 2019 Mar 27.
6
Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses?术前肾肿瘤活检能否改变临床实践并减少对小肾肿瘤的手术干预?
Urol Oncol. 2021 Oct;39(10):735.e17-735.e23. doi: 10.1016/j.urolonc.2021.05.024. Epub 2021 Aug 4.
7
Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses?在小肾肿瘤时代,经皮穿刺针活检是否仍具有当代作用?
BJU Int. 2012 Mar;109(6):867-72. doi: 10.1111/j.1464-410X.2011.10544.x. Epub 2011 Sep 2.
8
The contemporary role of renal mass biopsy in the management of small renal tumors.肾肿瘤活检在小肾肿瘤处理中的当代作用。
Front Oncol. 2012 Sep 10;2:106. doi: 10.3389/fonc.2012.00106. eCollection 2012.
9
Renal mass biopsy: A strategy to reduce associated costs and morbidity when managing localized renal masses.肾肿瘤活检:在处理局部肾肿瘤时降低相关成本和发病率的策略。
Urol Oncol. 2021 Nov;39(11):790.e9-790.e15. doi: 10.1016/j.urolonc.2021.06.015. Epub 2021 Jul 21.
10
The role of percutaneous renal biopsy in the management of small renal masses.经皮肾活检在小肾肿块治疗中的作用。
Curr Urol Rep. 2011 Feb;12(1):18-23. doi: 10.1007/s11934-010-0149-x.

引用本文的文献

1
In Pursuit of KI-RADS: Toward a Single, Evidence-based Imaging Classification of Renal Masses.追求肾脏影像报告和数据系统(KI-RADS):迈向基于证据的单一肾脏肿块影像分类
Radiology. 2025 Mar;314(3):e240308. doi: 10.1148/radiol.240308.
2
Diagnostic accuracy of the Clear Cell Likelihood Score and selected MRI parameters in the characterization of indeterminate renal masses - a single-institution study.Clear Cell 可能性评分和选定 MRI 参数在定性不确定肾肿块中的诊断准确性——单机构研究。
Abdom Radiol (NY). 2024 Nov;49(11):3893-3901. doi: 10.1007/s00261-024-04484-5. Epub 2024 Jul 9.
3
A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors.
基于放射组学的可解释模型预测胰腺神经内分泌肿瘤的病理分级。
Eur Radiol. 2024 Mar;34(3):1994-2005. doi: 10.1007/s00330-023-10186-1. Epub 2023 Sep 2.
4
Transfer learning-based approach for automated kidney segmentation on multiparametric MRI sequences.基于迁移学习的多参数MRI序列自动肾脏分割方法
J Med Imaging (Bellingham). 2022 May;9(3):036001. doi: 10.1117/1.JMI.9.3.036001. Epub 2022 Jun 16.
5
Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses.多中心评估在实性不确定小肾肿块中多参数 MRI 透明细胞可能性评分
Radiology. 2022 Jun;303(3):590-599. doi: 10.1148/radiol.211680. Epub 2022 Mar 15.
6
How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score.方法:采用 MRI 透明细胞似然评分管理不确定的肾脏肿块。
Radiology. 2022 Feb;302(2):256-269. doi: 10.1148/radiol.210034. Epub 2021 Dec 14.
7
Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.磁共振成像上透明细胞可能性评分与主动监测中小肾脏实性肿块生长动力学的关系。
AJR Am J Roentgenol. 2022 Jan;218(1):101-110. doi: 10.2214/AJR.21.25979. Epub 2021 Jul 21.
8
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.对肾癌生物学、评估及治疗的认识在25年中的演变与进展
Urol Oncol. 2021 Sep;39(9):548-560. doi: 10.1016/j.urolonc.2021.04.038. Epub 2021 Jun 4.
9
Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.利用定量多排螺旋CT增强参数鉴别透明细胞肾细胞癌与其他肾细胞癌亚型及良性嗜酸细胞瘤
Medicina (Kaunas). 2020 Oct 28;56(11):569. doi: 10.3390/medicina56110569.
10
Apparent Diffusion Coefficient Distinguishes Malignancy in T1-Hyperintense Small Renal Masses.表观弥散系数可区分 T1 高信号的小肾脏肿块中的良恶性病变。
AJR Am J Roentgenol. 2020 Jan;214(1):114-121. doi: 10.2214/AJR.19.21907. Epub 2019 Oct 1.